AG
KURA icon

Advisor Group’s Kura Oncology KURA Stock Holding History

Advisor Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Hold
478
– – ﹤0.01% 4585
2019
Q3 		$8K Hold
478
– – ﹤0.01% 4455
2019
Q2 		$9K Buy
478
+146
+44% +$2.42K ﹤0.01% 4427
2019
Q1 		$6K Buy
332
+98
+42% +$1.51K ﹤0.01% 4598
2018
Q4 		$3K Sell
234
-5
-2% -$66 ﹤0.01% 4716
2018
Q3 		$4K Buy
+239
New +$4.58K ﹤0.01% 4662

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Advisor Group's KURA Position: Q4 2019 in Review

Advisor Group held its Kura Oncology (KURA) position steady in Q4 2019 at 478 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4585.

Advisor Group first reported a position in KURA in Q3 2018 and has held it in 6 quarters since. The position peaked at $9K in Q2 2019. 127 funds tracked by Wall St. Rank hold KURA as of Q4 2019.

  • Advisor Group held 478 shares of Kura Oncology worth $6K as of Q4 2019.
  • Advisor Group left its Kura Oncology share count unchanged in Q4 2019.
  • Kura Oncology made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4585 holding.
  • Advisor Group first reported a position in Kura Oncology in Q3 2018 and has held it in 6 quarters since.
  • Advisor Group's Kura Oncology position peaked at $9K in Q2 2019.
  • 127 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.